Edwards Lifesciences Corp. (EW) reported earnings for second quarter that Drops, from the same period last year
The company's bottom line totaled $333.2 million, or $0.56 per share. This compares with $366.3 million, or $0.61 per share, last year.
Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $391.8 million or $0.67 per share for the period.
The company's revenue for the period rose 11.9% to $1.532 billion from $1.369 billion last year.
Edwards Lifesciences Corp. earnings at a glance (GAAP) :
-Earnings: $333.2 Mln. vs. $366.3 Mln. last year.-EPS: $0.56 vs. $0.61 last year.-Revenue: $1.532 Bln vs. $1.369 Bln last year.
-Guidance:Next quarter EPS guidance: $0.54 - $0.60Next quarter revenue guidance: $1.46 - $1.54 BlnFull year EPS guidance: $2.40 - $2.50Full year revenue guidance: $5.9 - $6.1 Bln
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.